How Often Should Shelf/Gellhorn Pessaries Be Changed? A Survey of IUGA Urogynaecologists
Overview
Urology
Authors
Affiliations
Introduction And Hypothesis: Gellhorn and shelf pessaries can be effective management for women with pelvic organ prolapse (POP). This study aimed to investigate the opinion of IUGA members about shelf/Gellhorn pessary use, and in particular, how often to change them in patients with POP. There are no evidence-based guidelines available on this subject.
Methods: Members of the International Urogynaecology Association (IUGA) and the British Society of Urogynaecology (BSUG) were sent a single electronic mailing of semi-structured questionnaires containing closed and open questions and free text response boxes. The internet-based survey consisted of 13 questions. Free text responses were analysed using a thematic qualitative analysis.
Results: A total of 322 respondents from the IUGA membership participated in the survey. Most consider shelf/Gellhorn pessaries an effective first-line treatment for their patients with POP. Self care is usually acceptable with ring pessaries, but with shelf/Gellhorn, 35 % would like to change them every 3 months, 31 % every 6 months and the rest varied. The routine use of oestrogens along with shelf/Gellhorn pessaries is a common practice. The risk of urogenital fistulae is well documented, but overall clinicians felt that shelf/Gellhorn pessaries are a safe and effective treatment for POP.
Conclusions: This study highlights the wide variation in global practice of the management of shelf/Gellhorn pessaries for POP. In order to inform our practice, evidence-based guidelines are required. A randomised control trial may help to decide whether or not it is appropriate to change the shelf/Gellhorn pessaries at all.
International Urogynecology Consultation Chapter 3 Committee 1 - Pessary Management.
Rantell A, Abdool Z, Fullerton M, Gedefaw A, Lough K, Miotla P Int Urogynecol J. 2025; .
PMID: 39873780 DOI: 10.1007/s00192-024-06020-x.
Dwyer L, Rajai A, Dowding D, Kearney R Int Urogynecol J. 2024; 35(8):1627-1634.
PMID: 38953998 PMC: 11380633. DOI: 10.1007/s00192-024-05840-1.
Dwyer L, Bugge C, Hagen S, Goodman K, Agur W, Dembinsky M Trials. 2022; 23(1):742.
PMID: 36064727 PMC: 9446823. DOI: 10.1186/s13063-022-06681-3.
Dwyer L, Dowding D, Kearney R BMJ Open. 2022; 12(7):e060223.
PMID: 35851026 PMC: 9297214. DOI: 10.1136/bmjopen-2021-060223.
Kadam Halani P, Gelman E, Duchein Y, Roselli N, Leegant A Female Pelvic Med Reconstr Surg. 2021; 28(2):121-125.
PMID: 34171881 PMC: 8808767. DOI: 10.1097/SPV.0000000000001085.